Joey Lancaster

Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis

J. Peter Cegielski, Tracy Dalton, Martín Yagui et al. · Clinical Infectious Diseases · 2014 · 150 citations · Full text

Public Health, Infectious Disease Control, Pharmacotherapy +13

Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence

Jason E. Farley, Malathi Ram, William Pan et al. · PLoS ONE · 2011 · 137 citations · Full text

Public Health, Pharmacotherapy, Antimicrobial Pharmacotherapy +14

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance

J. Peter Cegielski, Ekaterina V. Kurbatova, Martie van der Walt et al. · Clinical Infectious Diseases · 2015 · 101 citations · Full text

Life Sciences, Pharmacology, Antimicrobial Pharmacotherapy +14

Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study

Alyssa Finlay, Joey Lancaster, Timothy H. Holtz et al. · BMC Public Health · 2012 · 99 citations · Full text

Public Health, Infectious Disease Control, Clinical Epidemiology +15

Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008–2010

Ernesha Webb Mazinyo, Lindsay Kim, Sikhethiwe Masuku et al. · PLoS ONE · 2016 · 34 citations · Full text

Public Health, Infectious Disease Control, Communicable Disease Control +16